Charles Atkinson, MD
Surgery · Tucson, AZNPI 1871593731
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,170 of the $5,429 with a category attached, or 76.8%. Integra Lifesciences Corporation accounts for 88.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $4,408 and has fallen 92.1% since, to $347 in 2025.
Across 33 payments — averaging $164.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$5K
- Johnson & Johnson$215
- Covidien LP$145
- Intuitive Surgical$71
- Medtronic$53
- AbbVie$42
- plus $118 from 5 others
What the payments were for
- Consulting fees$4,17077%
- Food & beverage$1,25923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 18 | $4,785 |
| Johnson & Johnson | 3 | $215 |
| Covidien LP | 1 | $145 |
| Intuitive Surgical | 2 | $71 |
| Medtronic | 2 | $53 |
| AbbVie(2 entities) | 2 | $42 |
| Boston Scientific | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Surgenex LLC | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $18 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,429 in reported general payments places this provider in the 70th percentile of 614 surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $482 |
| Methocarbamol | 38 | $287 |
| Pantoprazole Sodium | 11 | $150 |
| Oxycodone Hcl | 25 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $80 |
| Neomycin Sulfate | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tucson
- Rifat LatifiTucson$144K
- Katie ArtzTucson$103K
- Jenelle OlsonTucson$72K
- Stuart MelcerTucson$71K
- Andrew NejadTucson$57K
- Tiffany SonTucson$47K
- Patrick ChiassonTucson$46K
- Michael ProbstfeldTucson$46K
- Guillermo Higa SansoneTucson$42K
- Kelly LaraTucson$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.